Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Healthcare (Basel, Switzerland)|June 26, 2025
Variations in Methodological Approaches to Measuring Health Inequalities and Inequities: A Scoping Review of Acute Stroke PathwaysStephen McCarthy, Peter McMeekin, Michael Allen, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 25, 2018
Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provincesDixon T S Woon, Thenappan Chandrasekar, Lorne Aaron, et al.
Nutrients|December 31, 2025
Interactions Between Sarcopenia, Physical Frailty and Resting Energy Expenditure in Cirrhosis and Portal HypertensionRachael Jacob, Joanne Craik, Aviv Pudipeddi, et al.
F&S Science|May 13, 2022
Exogenous insulin-like growth factor 1 accelerates growth and maturation of follicles in human cortical xenografts and increases ovarian output in miceLimor Man, Nicole Lustgarten Guahmich, Eleni Kallinos, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 27, 2020
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selectionPeter C Black, Nimira S Alimohamed, David Berman, et al.
JAMA Dermatology|December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality ImprovementAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 28, 2020
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialistsSebastien J Hotte, Antonio Finelli, Kim N Chi, et al.
Blood|May 26, 2016
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cellsAmy Sinclair, Laura Park, Mansi Shah, et al.
The British Journal of Dermatology|August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site InvolvementLinda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.
JNCI Cancer Spectrum|December 20, 2021
Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate CancerChristopher J D Wallis, Shawn Malone, Ilias Cagiannos, et al.
Pageof 4